Disease management in farmed Atlantic salmon involves complex welfare trade-offs between treatment procedures, chronic disease burden, and the use of cleaner fish with their own welfare needs.
Salmon disease management welfare involves a cascade of welfare considerations: the chronic welfare harm of untreated disease, the acute welfare harm of treatment procedures, and the welfare of any cleaner fish used as biological control agents. No treatment is welfare-neutral, but the alternative of chronic lice or gill disease infestation causes progressive suffering. Management approaches that reduce disease pressure through genetics, site management, and vaccination - thereby minimizing the frequency and intensity of treatments needed - represent the welfare-positive aspiration. Industry investment in selective breeding for disease resistance is one of the most promising long-term welfare improvement pathways for farmed salmon.